lobbying_activities: 2511390
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2511390 | 9b637d25-9dc7-4598-8d61-5d0d0df4f084 | Q3 | BURRELL INTERNATIONAL GROUP LLC | 401103483 | ACER THERAPEUTICS | 2020 | third_quarter | PHA | COVID 19 therapeutics and Medical Countermeasures, Rare Disease and Re-purposed drugs | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-10-16T14:30:37.973000-04:00 |